AC Immune SA reports results for the quarter ended in March - Earnings Summary

AC Immune SA

03/05/2022 06:51

* AC Immune SA  ACIU.OQ  reported a quarterly adjusted loss
of 23
rappen​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 22 rappen per share.
    * Reported revenue was zero​;  analysts expected CHF233.33
thousand. 
    * AC Immune SA's reported EPS for the quarter was a loss
of 23
rappen​.
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * AC Immune SA shares had fallen by 14.0% this quarter and
lost 30.5% so far this year.
    * The company reported a quarterly loss of CHF18.84 million.
    * Wall Street's median 12-month price target for AC Immune
SA is
$15.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 3 at 05:51 a.m.  ​All
figures in Swiss francs unless otherwise stated